TMX Newsfile

IN THE PRESS

Entheon Biomedical Announces Sponsorship of a Clinical Study to Assess the Electroneurophysiologic Effects of Ketamine

August 12, 2021

·

5 min read

Awakn Life Sciences Begins Trading on the OTCQB(R) Venture Market Under the Symbol ‘AWKNF’ on August 12th

August 12, 2021

·

3 min read

Defence Therapeutics Receives DTC Eligibility

August 11, 2021

·

2 min read

Drug Development

Annovis Bio Completes Dosing of Parkinson’s Disease Patients with ANVS401 in Phase 2a Clinical Trial

August 11, 2021

·

3 min read

Business

Halberd Corporation Adds Blood-Borne Disease Treatment Capability with Addition of Noted Nephrologist

August 11, 2021

·

5 min read

Biotech Beach

Tryp Therapeutics Partners with Calvert Labs to Conduct Exploratory Studies for Proprietary Psilocybin Formulations

August 10, 2021

·

5 min read

NervGen Pharma and Massachusetts General Hospital Collaborate on Preclinical Studies in Alzheimer’s Disease

August 9, 2021

·

8 min read

Telo Genomics Engages Clinical and Regulatory Affairs Veteran to Lead the Company’s ISO 15189 Certification & CLIA Laboratory Accreditation Undertaking

August 9, 2021

·

4 min read

Pharm Country

Halberd Corporation’s VITA-SHIELD-MAX(TM) Immunity Support Product Shipped

August 9, 2021

·

3 min read

Cardiol Therapeutics to Commence Trading on NASDAQ Under the Symbol “CRDL”

August 9, 2021

·

4 min read

15 Toronto St., Suite 601 Toronto ON M5C 2E3 US

Tel: 416-806-1750